Banque Cantonale Vaudoise Biogen Inc. Transaction History

Banque Cantonale Vaudoise

$2.55 Billion
Q1 2024

A detailed history of Banque Cantonale Vaudoise transactions in Biogen Inc. stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 2,917 shares of BIIB stock, worth $658,221. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,917

Previous 4,422 34.03%

Holding current value

$658,221

Previous $1.15 Million 44.98%

% of portfolio

0.02%

Previous 0.05%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 10, 2024	SELL	$212.02 - $267.71 $319,090 - $402,903	-1,505 Reduced 34.03%	2,917 $630,000
Q4 2023 Feb 07, 2024	SELL	$222.59 - $267.94 $309,622 - $372,704	-1,391 Reduced 23.93%	4,422 $1.15 Million
Q3 2023 Nov 08, 2023	SELL	$253.3 - $285.89 $166,924 - $188,401	-659 Reduced 10.18%	5,813 $1.5 Million
Q2 2023 Aug 09, 2023	BUY	$275.25 - $318.06 $92,484 - $106,868	336 Added 5.48%	6,472 $1.84 Million
Q1 2023 Apr 20, 2023	BUY	$256.56 - $292.34 $51,312 - $58,467	200 Added 3.37%	6,136 $1.71 Million

Q4 2022 Feb 10, 2023	SELL	$252.44 - $306.72 $154,240 - $187,405	-611 Reduced 9.33%	5,936 $1.64 Million
Q3 2022 Oct 17, 2022	BUY	$194.69 - $268.46 $389 - $536	2 Added 0.03%	6,547 $1.75 Million
Q2 2022 Aug 02, 2022	SELL	$187.54 - $223.02 $216,046 - $256,919	-1,152 Reduced 14.97%	6,545 $1.34 Million
Q1 2022 May 09, 2022	SELL	$193.77 - $244.14 $31,196 - $39,306	-161 Reduced 2.05%	7,697 $1.62 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $86,880 - $111,654	-388 Reduced 4.71%	7,858 $1.89 Million
Q3 2021 Oct 29, 2021	BUY	$282.99 - $369.05 $79,237 - $103,334	280 Added 3.51%	8,246 $2.33 Million
Q2 2021 Aug 11, 2021	SELL	$259.0 - $414.71 $287,490 - $460,328	-1,110 Reduced 12.23%	7,966 $2.76 Million
Q1 2021 May 11, 2021	BUY	$242.95 - $284.63 $492,216 - $576,660	2,026 Added 28.74%	9,076 $2.54 Million
Q4 2020 Feb 05, 2021	SELL	$236.26 - $355.63 $29,059 - $43,742	-123 Reduced 1.71%	7,050 $1.73 Million
Q3 2020 Oct 30, 2020	SELL	$264.77 - $305.71 $531,658 - $613,865	-2,008 Reduced 21.87%	7,173 $2.03 Million
Q2 2020 Jul 22, 2020	BUY	$258.66 - $342.55 $543,186 - $719,355	2,100 Added 29.66%	9,181 $2.46 Million
Q1 2020 May 14, 2020	BUY	$268.85 - $341.04 $537,700 - $682,080	2,000 Added 39.36%	7,081 $2.24 Million
Q4 2019 Feb 10, 2020	BUY	$220.06 - $304.07 $1.12 Million - $1.54 Million	5,081 New	5,081 $1.51 Million

Others Institutions Holding BIIB

# of Institutions

1,047

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.

Account

Banque Cantonale Vaudoise Biogen Inc. Transaction History